Zecyte (Abiraterone acetate) treats advanced prostate cancer, including metastatic castration-resistant prostate cancer (CRPC) and high-risk metastatic castration-sensitive prostate cancer (CSPC) (mayoclinic.org). It works by inhibiting the enzyme CYP17, which reduces testosterone production that fuels cancer growth. Consequently, Zecyte slows tumor progression and supports long-term treatment goals.

Key Benefits & Uses

• Zecyte effectively treats metastatic CRPC and high-risk metastatic CSPC.

• When combined with other therapies, it improves treatment outcomes.

• Clinical studies show it increases survival rates and delays disease progression (cancer.gov).

How to Use

Take Zecyte tablets once daily on an empty stomach—at least 2 hours after eating and 1 hour before your next meal. Swallow the tablets whole with water, and avoid chewing or crushing them. Always take Zecyte alongside prednisone as prescribed by your healthcare provider (dailymed.nlm.nih.gov). This routine maximizes effectiveness.

Important Safety Information

Avoid Zecyte if you are or may become pregnant, as it can harm the fetus (accessdata.fda.gov). Furthermore, it may raise blood pressure, lower potassium, cause fluid retention, or affect liver function. Therefore, doctors regularly monitor blood pressure, liver function, and potassium levels during treatment (dailymed.nlm.nih.gov).

Common Side Effects

• Hot flashes

• Headache

• Diarrhea

• Joint pain or swelling

• Fatigue

• Elevated liver enzymes

• Low potassium levels (webmd.com)

Why Choose Zecyte?

Zecyte targets androgen production, which fuels prostate cancer. Moreover, combining it with prednisone improves survival rates and slows disease progression (cancer.gov). Consequently, patients receive a focused therapy designed for advanced prostate cancer management.